chitosan has been researched along with Keratitis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 6 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, D; Han, L; Li, J; Li, Z; Liang, Z; Liu, R; Shen, J; Shi, L; Zhang, J; Zhu, L | 1 |
| Chu, X; Deng, Z; Guo, H; Huo, Q; Jiao, Z; Lin, X; Lu, S; Peng, Y; Wang, B; Wang, X; Zhou, X | 1 |
| Kesavan, K; Mohan, P; Rangari, VD | 1 |
| Akhir, A; Bhatta, RS; Bisen, AC; Chopra, S; Kedar, A; Krishna, A; Mugale, MN; Sanap, SN; Yadav, KS | 1 |
| Biswas, S; Ch, S; Ghosh, B; Padaga, SG; Roy, S | 1 |
| Chang, YF; Cheng, YH; Ko, YC; Liu, CJ | 1 |
| Dua, HS; Messina, M | 1 |
| Bozbıyık, Dİ; Eğrilmez, S; Ertan, G; Gökçe, EH; Ozer, O; Ustündağ-Okur, N | 1 |
| Fu, T; Lv, S; Yi, J; Zhang, B | 1 |
| Badawi, AA; El dally, M; El Mofty, H; El Qidra, RK; El-Laithy, HM | 1 |
10 other study(ies) available for chitosan and Keratitis
| Article | Year |
|---|---|
A dual-functional chitosan derivative platform for fungal keratitis.
Topics: Administration, Ophthalmic; Animals; Antifungal Agents; Biocompatible Materials; Carbohydrate Conformation; Chitosan; Drug Delivery Systems; Eye Infections, Fungal; Female; Fusarium; Humans; Keratitis; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Ophthalmic Solutions | 2022 |
Drug-free contact lens based on quaternized chitosan and tannic acid for bacterial keratitis therapy and corneal repair.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Contact Lenses; Escherichia coli; Hydrogels; Keratitis; Tannins | 2022 |
Cationic Chitosan/Pectin Polyelectrolyte Nanocapsules of Moxifloxacin as Novel Topical Management System for Bacterial Keratitis.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Cornea; Delayed-Action Preparations; Fluoroquinolones; Keratitis; Moxifloxacin; Nanocapsules; Particle Size; Pectins; Polyelectrolytes; Rabbits | 2022 |
Chitosan/HPMC-based mucoadhesive film co-loaded with fluconazole and ofloxacin for management of polymicrobial keratitis.
Topics: Chitosan; Drug Compounding; Drug Delivery Systems; Fluconazole; Humans; Keratitis; Ofloxacin | 2022 |
Chitosan-poly(lactide-co-glycolide)/poloxamer mixed micelles as a mucoadhesive thermo-responsive moxifloxacin eye drop to improve treatment efficacy in bacterial keratitis.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Humans; Keratitis; Mice; Micelles; Moxifloxacin; Ophthalmic Solutions; Poloxamer; Polyglactin 910; Staphylococcus aureus; Treatment Outcome | 2023 |
Development of a dual delivery of levofloxacin and prednisolone acetate via PLGA nanoparticles/ thermosensitive chitosan-based hydrogel for postoperative management: An in-vitro and ex-vivo study.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Chitosan; Cytokines; Disease Models, Animal; Drug Carriers; Drug Liberation; Drug Therapy, Combination; Endophthalmitis; Epithelial Cells; Epithelium, Corneal; Hydrogels; Keratitis; Levofloxacin; Nanoparticles; Particle Size; Postoperative Complications; Prednisolone; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Temperature | 2021 |
Early results on the use of chitosan-N-acetylcysteine (Lacrimera
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Chitosan; Dry Eye Syndromes; Female; Follow-Up Studies; Humans; Keratitis; Lubricant Eye Drops; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Time Factors; Treatment Outcome | 2019 |
Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Drug Carriers; Escherichia coli; Hydrogen-Ion Concentration; Keratitis; Lactates; Lipids; Male; Microbial Sensitivity Tests; Nanoparticles; Ofloxacin; Particle Size; Rabbits; Staphylococcus aureus; Surface Properties; Viscosity | 2014 |
Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Topics: Administration, Ophthalmic; Amphotericin B; Animals; Antifungal Agents; Biological Availability; Chitosan; Delayed-Action Preparations; Drug Compounding; Emulsions; Eye Infections, Fungal; Keratitis; Lipids; Liposomes; Male; Nanoparticles; Particle Size; Permeability; Rabbits | 2017 |
Chitosan based nanocarriers for indomethacin ocular delivery.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Area Under Curve; Chemical Phenomena; Chemistry, Physical; Chitosan; Cornea; Drug Delivery Systems; Drug Stability; Emulsions; Excipients; Indomethacin; Keratitis; Male; Microscopy, Electron, Transmission; Nanoparticles; Ophthalmic Solutions; Particle Size; Powders; Rabbits; Reference Standards; Solutions | 2008 |